Similarities and differences between the UDMI-4 and Society of Cardiovascular Angiography and Interventions for periprocedural myocardial infarction
| . | UDMI-4 . | SCAI . |
|---|---|---|
| Biomarker | Only cTn | Preferably CK-MB, cTn secondary |
| Differentiation between PCI and CABG | Yes | No |
| PCI | ||
| ECG findings | All new ischaemic changes, including T-wave inversion and all ST-segment deviations | New Q-waves in >1 continuous lead, new persistent LBBB |
| Imaging findings | New loss of viable myocardium, new RWMA, angiographic evidence | NA |
| Biomarker cut-offs warranting additional evidence | ||
| cTn | >5 × URL | >35 × ULN |
| CK-MB | NA | >5 × ULN |
| Solitary biomarker cut-offs | ||
| cTn | NA | >70 × ULN |
| CK-MB | NA | >10 × ULN |
| CABG | ||
| ECG findings | Only new Q-waves in >1 continuous lead, new persistent LBBB or ST-segment elevation with reciprocal depression | New Q-waves in >1 continuous lead, new persistent LBBB |
| Imaging findings | New RWMA on | NA |
| Biomarker cut-offs warranting additional evidence | ||
| cTn | >10 × URL | >35 × ULN |
| CK-MB | NA | >5 × ULN |
| Solitary biomarker cut-offs | ||
| cTn | NA | >70 × ULN |
| CK-MB | NA | >10 × ULN |
| . | UDMI-4 . | SCAI . |
|---|---|---|
| Biomarker | Only cTn | Preferably CK-MB, cTn secondary |
| Differentiation between PCI and CABG | Yes | No |
| PCI | ||
| ECG findings | All new ischaemic changes, including T-wave inversion and all ST-segment deviations | New Q-waves in >1 continuous lead, new persistent LBBB |
| Imaging findings | New loss of viable myocardium, new RWMA, angiographic evidence | NA |
| Biomarker cut-offs warranting additional evidence | ||
| cTn | >5 × URL | >35 × ULN |
| CK-MB | NA | >5 × ULN |
| Solitary biomarker cut-offs | ||
| cTn | NA | >70 × ULN |
| CK-MB | NA | >10 × ULN |
| CABG | ||
| ECG findings | Only new Q-waves in >1 continuous lead, new persistent LBBB or ST-segment elevation with reciprocal depression | New Q-waves in >1 continuous lead, new persistent LBBB |
| Imaging findings | New RWMA on | NA |
| Biomarker cut-offs warranting additional evidence | ||
| cTn | >10 × URL | >35 × ULN |
| CK-MB | NA | >5 × ULN |
| Solitary biomarker cut-offs | ||
| cTn | NA | >70 × ULN |
| CK-MB | NA | >10 × ULN |
CABG: coronary artery bypass grafting; CK-MB: creatine kinase myocardial band; cTn: cardiac troponin T; ECG: electrocardiography; LBBB: left bundle branch block; NA: not applicable; RWMA: regional wall motion abnormalities; SCAI: Society for Cardiovascular Angiography and Interventions; UDMI: universal definition of myocardial infarction; ULN: upper limit of normal; URL: upper reference limit.
Similarities and differences between the UDMI-4 and Society of Cardiovascular Angiography and Interventions for periprocedural myocardial infarction
| . | UDMI-4 . | SCAI . |
|---|---|---|
| Biomarker | Only cTn | Preferably CK-MB, cTn secondary |
| Differentiation between PCI and CABG | Yes | No |
| PCI | ||
| ECG findings | All new ischaemic changes, including T-wave inversion and all ST-segment deviations | New Q-waves in >1 continuous lead, new persistent LBBB |
| Imaging findings | New loss of viable myocardium, new RWMA, angiographic evidence | NA |
| Biomarker cut-offs warranting additional evidence | ||
| cTn | >5 × URL | >35 × ULN |
| CK-MB | NA | >5 × ULN |
| Solitary biomarker cut-offs | ||
| cTn | NA | >70 × ULN |
| CK-MB | NA | >10 × ULN |
| CABG | ||
| ECG findings | Only new Q-waves in >1 continuous lead, new persistent LBBB or ST-segment elevation with reciprocal depression | New Q-waves in >1 continuous lead, new persistent LBBB |
| Imaging findings | New RWMA on | NA |
| Biomarker cut-offs warranting additional evidence | ||
| cTn | >10 × URL | >35 × ULN |
| CK-MB | NA | >5 × ULN |
| Solitary biomarker cut-offs | ||
| cTn | NA | >70 × ULN |
| CK-MB | NA | >10 × ULN |
| . | UDMI-4 . | SCAI . |
|---|---|---|
| Biomarker | Only cTn | Preferably CK-MB, cTn secondary |
| Differentiation between PCI and CABG | Yes | No |
| PCI | ||
| ECG findings | All new ischaemic changes, including T-wave inversion and all ST-segment deviations | New Q-waves in >1 continuous lead, new persistent LBBB |
| Imaging findings | New loss of viable myocardium, new RWMA, angiographic evidence | NA |
| Biomarker cut-offs warranting additional evidence | ||
| cTn | >5 × URL | >35 × ULN |
| CK-MB | NA | >5 × ULN |
| Solitary biomarker cut-offs | ||
| cTn | NA | >70 × ULN |
| CK-MB | NA | >10 × ULN |
| CABG | ||
| ECG findings | Only new Q-waves in >1 continuous lead, new persistent LBBB or ST-segment elevation with reciprocal depression | New Q-waves in >1 continuous lead, new persistent LBBB |
| Imaging findings | New RWMA on | NA |
| Biomarker cut-offs warranting additional evidence | ||
| cTn | >10 × URL | >35 × ULN |
| CK-MB | NA | >5 × ULN |
| Solitary biomarker cut-offs | ||
| cTn | NA | >70 × ULN |
| CK-MB | NA | >10 × ULN |
CABG: coronary artery bypass grafting; CK-MB: creatine kinase myocardial band; cTn: cardiac troponin T; ECG: electrocardiography; LBBB: left bundle branch block; NA: not applicable; RWMA: regional wall motion abnormalities; SCAI: Society for Cardiovascular Angiography and Interventions; UDMI: universal definition of myocardial infarction; ULN: upper limit of normal; URL: upper reference limit.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
